Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triptorelin oral contraceptive pill flare-up versus GnRH-antagonist in IVF/ICSI
NL-OMON29309Suspended
- Sponsor
- VU University Medical Center, Department of Obstetrics and Gynaecology
- Start
- Jan 2011
- Modality
- Small Molecules, Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of triptorelin, cetrorelix and menotropins in female infertility (2 arms), sponsored by VU University Medical Center, Department of Obstetrics and Gynaecology. Primary endpoint: Incidence of premature serum LH surges. Started Jan 2011; status: suspended.
02
Drugs
triptorelincetrorelixmenotropins
03
Conditions
female infertility
Beyond the preview
Go deeper on NL-OMON29309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29309.